Your browser doesn't support javascript.
loading
MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters.
Benesch, M; Perwein, T; Apfaltrer, G; Langer, T; Neumann, A; Brecht, I B; Schuhmann, M U; Cario, H; Frühwald, M C; Vollert, K; van Buiren, M; Deng, M Y; Seitz, A; Haberler, C; Mynarek, M; Kramm, C; Sahm, F; Robe, P A; Dankbaar, J W; Hoff, K V; Warmuth-Metz, M; Bison, B.
Affiliation
  • Benesch M; From the Division of Pediatric Hematology and Oncology (M.B., T.P.), Department of Pediatrics and Adolescent Medicine.
  • Perwein T; From the Division of Pediatric Hematology and Oncology (M.B., T.P.), Department of Pediatrics and Adolescent Medicine thomas.perwein@medunigraz.at.
  • Apfaltrer G; Division of Pediatric Radiology (G.A.), Department of Radiology, Medical University Graz, Graz, Austria.
  • Langer T; Departments of Pediatrics (T.L.).
  • Neumann A; Neuroradiology (A.N.), University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Brecht IB; Pediatric Hematology and Oncology (I.B.B.), Children's Hospital.
  • Schuhmann MU; Division of Pediatric Neurosurgery (M.U.S.), Department of Neurosurgery, Eberhard-Karls University Tübingen, Tübingen, Germany.
  • Cario H; Department of Pediatrics and Adolescent Medicine (H.C.), Ulm University Medical Center, Ulm, Germany.
  • Frühwald MC; Swabian Children's Cancer Center (M.C.F.).
  • Vollert K; Pediatric and Adolescent Medicine and Departments of Diagnostic and Interventional Radiology and Neuroradiology (K.V., B.B.), University Medical Center Augsburg, Augsburg, Germany.
  • van Buiren M; Department of Pediatric Hematology and Oncology (M.v.B.), Center for Pediatrics, Medical Center-University of Freiburg, Freiburg, Germany.
  • Deng MY; Hopp Children's Cancer Center Heidelberg (M.Y.D., F.S.).
  • Seitz A; German Cancer Research Center and Department of Neuroradiology (A.S.).
  • Haberler C; Division of Neuropathology and Neurochemistry (C.H.), Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Mynarek M; Department of Pediatric Hematology and Oncology (M.M.).
  • Kramm C; Mildred Scheel Cancer Career Center (M.M.), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sahm F; Division of Pediatric Hematology and Oncology (C.K.), University Medical Center Göttingen, Göttingen, Germany.
  • Robe PA; Hopp Children's Cancer Center Heidelberg (M.Y.D., F.S.).
  • Dankbaar JW; Department of Neuropathology (F.S.), Institute of Pathology.
  • Hoff KV; Clinical Cooperation Unit Neuropathology (F.S.), German Cancer Consortium, German Cancer Research Center, Heidelberg University Hospital, Heidelberg, Germany.
  • Warmuth-Metz M; Department of Neurology and Neurosurgery (P.A.R.).
  • Bison B; Department of Radiology (J.W.D.), University Medical Center Utrecht, Utrecht, the Netherlands.
AJNR Am J Neuroradiol ; 43(10): 1523-1529, 2022 10.
Article in En | MEDLINE | ID: mdl-36137663
ABSTRACT
BACKGROUND AND

PURPOSE:

Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC) is a new, molecularly defined glioneuronal CNS tumor type. The objective of the present study was to describe MR imaging and clinical characteristics of patients with DGONC. MATERIALS AND

METHODS:

Preoperative MR images of 9 patients with DGONC (median age at diagnosis, 9.9 years; range, 4.2-21.8 years) were reviewed.

RESULTS:

All tumors were located superficially in the frontal/temporal lobes and sharply delineated, displaying little mass effect. Near the circle of Willis, the tumors encompassed the arteries. All except one demonstrated characteristics of low-to-intermediate aggressiveness with high-to-intermediate T2WI and ADC signals and bone remodeling. Most tumors (n = 7) showed a homogeneous ground-glass aspect on T2-weighted and FLAIR images. On the basis of the original histopathologic diagnosis, 6 patients received postsurgical chemo-/radiotherapy, 2 were irradiated after surgery, and 1 patient underwent tumor resection only. At a median follow-up of 61 months (range, 10-154 months), 6 patients were alive in a first complete remission and 2 with stable disease 10 and 21 months after diagnosis. The only patient with progressive disease was lost to follow-up. Five-year overall and event-free survival was 100% and 86±13%, respectively.

CONCLUSIONS:

This case series presents radiomorphologic characteristics highly predictive of DGONC that contrast with the typical aspects of the original histopathologic diagnoses. This presentation underlines the definition of DGONC as a separate entity, from a clinical perspective. Complete resection may be favorable for long-term disease control in patients with DGONC. The efficacy of nonsurgical treatment modalities should be evaluated in larger series.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligodendroglioma / Brain Neoplasms / Central Nervous System Neoplasms / Neoplasms, Neuroepithelial / Glioma Type of study: Prognostic_studies Limits: Child / Humans Language: En Journal: AJNR Am J Neuroradiol Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligodendroglioma / Brain Neoplasms / Central Nervous System Neoplasms / Neoplasms, Neuroepithelial / Glioma Type of study: Prognostic_studies Limits: Child / Humans Language: En Journal: AJNR Am J Neuroradiol Year: 2022 Type: Article